Publications by authors named "Hiroki Tojima"

Claim this Profile
P
Postpartum Hepatitis B Exacerbation Following Discontinuation of Nucleotide Analogue Therapy: A Case Report.
Ryo Takada, Soichiro Shimizu, Yuichi Yamazaki, Yumeo Tateyama, Toru Fukuchi, Hiroki Tojima

Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualization and endoscopic treatment of ruptured anastomotic varices using red dichromatic imaging: a case report.
Tatsuma Murakami, Yuichi Yamazaki, Aung Paing Moe, Aoi Kita, Yumeo Tateyama, Hiroki Tojima

Clin J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan.
Yoshio Tokumoto, Yoichi Hiasa, Yoshihito Uchida, Takashi Oono, Atsushi Yukimoto, Hiroki Tojima

Hepatol Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Resected Case of Hepatic Angiomyolipoma with Tumor Hemorrhage and Undetectable Fat Causing Diagnostic Difficulty.
Yumeo Tateyama, Yuichi Yamazaki, Ayaka Katayama, Tatsuma Murakami, Hiroki Tojima

Surg Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Efficacy of Lusutrombopag for Chronic Liver Disease Based on Pre-Treatment Platelet Counts: A Retrospective Multicenter Study.
Takayoshi Suga, Satoru Kakizaki, Atsushi Naganuma, Takeshi Hatanaka, Satoshi Takakusagi, Hiroki Tojima

JGH Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab.
Naoto Saito, Takeshi Hatanaka, Sachi Nakano, Yoichi Hazama, Sachiko Yoshida, Hiroki Tojima

Clin Case Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct-acting antivirals.
Satoshi Takakusagi, Naoto Saito, Takashi Ueno, Takeshi Hatanaka, Masashi Namikawa, Hiroki Tojima

DEN Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Liver injury in patients with moderate II COVID-19 who received dexamethasone monotherapy].
Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Takayoshi Suga, Hirohito Tanaka, Hiroki Tojima

Nihon Shokakibyo Gakkai Zasshi· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy.
Ken Sato, Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Hiroki Tojima

Clin Case Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy.
Ken Sato, Yuki Kanayama, Yuichi Yamazaki, Hiroki Tojima, Takayoshi Suga

Clin J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice.
Yuichi Yamazaki, Yuka Yoshida, Megumi Shimizu, Takeshi Kobayashi, Hiroki Tojima

Intern Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately.
Hiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, Takashi Hoshino, Atsushi Naganuma

Intern Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score.
Takeshi Hatanaka, Takashi Kosone, Naoto Saito, Satoshi Takakusagi, Hiroki Tojima

JGH Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative Study.
Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, Masashi Namikawa, Takashi Ueno, Hiroki Tojima

Oncology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of lenvatinib as third-line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
Atsushi Hiraoka, Takashi Kumada, Takeshi Hatanaka, Toshifumi Tada, Kazuya Kariyama, Hiroki Tojima

Hepatol Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pemafibrate in Patients with Hypertriglyceridemia and Metabolic Dysfunction-associated Fatty Liver Disease Pathologically Diagnosed with Non-alcoholic Steatohepatitis: A Retrospective, Single-arm Study.
Takeshi Hatanaka, Satoru Kakizaki, Naoto Saito, Yuya Nakano, Sachi Nakano, Hiroki Tojima

Intern Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first reported case of Noonan syndrome complicated with hepatocellular carcinoma.
Satoru Kakizaki, Daisuke Uehara, Hiroki Tojima, Takayoshi Suga, Yuichi Yamazaki

Clin Case Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of F-fluoro-2-deoxyglucose position-emission tomography findings by the eradication of Helicobacter pylori in the stomach.
Kyoko Marubashi, Satoshi Takakusagi, Yozo Yokoyama, Kazuko Kizawa, Takashi Kosone, Hiroki Tojima

Helicobacter· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment.
Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, Masashi Namikawa, Takashi Ueno, Hiroki Tojima

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling.
Takayoshi Suga, Ken Sato, Tatsuya Ohyama, Sho Matsui, Takeshi Kobayashi, Hiroki Tojima

World J Hepatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure.
Hiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, Takashi Hoshino, Atsushi Naganuma

Hepatol Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study.
Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, Masashi Namikawa, Hiroki Tojima

Hepatol Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
Daisuke Uehara, Yosuke Seki, Satoru Kakizaki, Norio Horiguchi, Hiroki Tojima

Obes Surg· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis.
Daisuke Uehara, Hiroki Tojima, Satoru Kakizaki, Yuichi Yamazaki, Norio Horiguchi

Dig Liver Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology.
Daisuke Uehara, Yoichi Hayashi, Yosuke Seki, Satoru Kakizaki, Norio Horiguchi, Hiroki Tojima

World J Hepatol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis